These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7037510)

  • 1. Lack of glucagon response in glucose counter-regulation in type 1 (insulin-dependent) diabetics: absence of recovery after prolonged optimal insulin therapy.
    Bolli G; Calabrese G; De Feo P; Compagnucci P; Zega G; Angeletti G; Cartechini MG; Santeusanio F; Brunetti P
    Diabetologia; 1982 Feb; 22(2):100-5. PubMed ID: 7037510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
    Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of counter-regulatory abnormalities in insulin-dependent diabetes mellitus after pancreas transplantation.
    Battezzati A; Luzi L; Perseghin G; Bianchi E; Spotti D; Secchi A; Vergani S; Di Carlo V; Pozza G
    Eur J Clin Invest; 1994 Nov; 24(11):751-8. PubMed ID: 7890013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albiglutide does not impair the counter-regulatory hormone response to hypoglycaemia: a randomized, double-blind, placebo-controlled, stepped glucose clamp study in subjects with type 2 diabetes mellitus.
    Hompesch M; Jones-Leone A; Carr MC; Matthews J; Zhi H; Young M; Morrow L; Reinhardt RR
    Diabetes Obes Metab; 2015 Jan; 17(1):82-90. PubMed ID: 25263215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon release and glucose counter-regulation during hypoglycaemia. Modifying effect of the previous glucose level.
    Lager I; von Schenck H; Smith U
    Acta Endocrinol (Copenh); 1985 Sep; 110(1):107-13. PubMed ID: 3898692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved but not normalized glucose counter-regulation during glucagon infusion in Type 1 (insulin-dependent) diabetes.
    Lager I; von Schenck H; Smith U
    Diabetologia; 1984 May; 26(5):337-42. PubMed ID: 6376242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia.
    Porcellati F; Pampanelli S; Rossetti P; Busciantella Ricci N; Marzotti S; Lucidi P; Santeusanio F; Bolli GB; Fanelli CG
    Diabetologia; 2007 Feb; 50(2):422-30. PubMed ID: 17160672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exogenously administered glucagon versus spontaneous endogenous counter-regulation on glycaemic recovery from insulin-induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin.
    Krentz AJ; Morrow L; Petersson M; Norjavaara E; Hompesch M
    Diabetes Obes Metab; 2014 Nov; 16(11):1096-101. PubMed ID: 24909093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term administration of theophylline and glucose recovery after hypoglycaemia in patients with type 1 diabetes mellitus.
    Hvidberg A; Rosenfalck A; Christensen NJ; Hilsted J
    Diabet Med; 1998 Jul; 15(7):608-14. PubMed ID: 9686702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective blood glucose counter-regulation in diabetics is a selective form of autonomic neuropathy.
    Campbell LV; Kraegen EW; Lazarus L
    Br Med J; 1977 Dec; 2(6101):1527-9. PubMed ID: 589316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intranasal glucagon on blood glucose levels in healthy subjects and hypoglycaemic patients with insulin-dependent diabetes.
    Freychet L; Rizkalla SW; Desplanque N; Basdevant A; Zirinis P; Tchobroutsky G; Slama G
    Lancet; 1988 Jun; 1(8599):1364-6. PubMed ID: 2898045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans.
    Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Ciofetta M; Modarelli F; Di Vincenzo A; Annibale B; Lepore M; Lalli C
    Diabetologia; 1994 Aug; 37(8):797-807. PubMed ID: 7988782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects.
    Peacey SR; George E; Rostami-Hodjegan A; Bedford C; Harris N; Hardisty CA; Tucker GT; Macdonald IA; Heller SR
    Diabet Med; 1996 Jul; 13(7):634-41. PubMed ID: 8840097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon is absorbed from the rectum but does not hasten recovery from hypoglycaemia in patients with type 1 diabetes.
    Parker DR; Braatvedt GD; Bargiota A; Newrick PG; Brown S; Gamble G; Corrall RJ
    Br J Clin Pharmacol; 2008 Jul; 66(1):43-9. PubMed ID: 18507661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired counter regulation of hypoglycemia in a group of insulin-dependent diabetics with recurrent episodes of severe hypoglycemia.
    Adamson U; Lins PE; Efendic S; Hamberger B; Wajngot A
    Acta Med Scand; 1984; 216(2):215-22. PubMed ID: 6388251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycaemia in insulin-dependent diabetics.
    Volpi R; Chiodera P; Capretti L; Caffarri G; Giuliani N; Caiazza A; Coiro V
    J Intern Med; 1998 Jul; 244(1):43-8. PubMed ID: 9698023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased splanchnic blood flow after hypoglycaemia in diabetic and normal man: evidence against glucagon as a mediator.
    Parker DR; Bargiota A; Braatvedt GD; Halliwell M; Corrall RJ
    Clin Sci (Lond); 1999 Feb; 96(2):179-84. PubMed ID: 9918898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
    Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
    Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas).
    Nosadini R; Noy GA; Nattrass M; Alberti KG; Johnston DG; Home PD; Orskov H
    Diabetologia; 1982 Sep; 23(3):220-8. PubMed ID: 6751902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.